Critical Path Institute's Predictive Safety Testing Consortium Announces Special Issue of Nature Biotechnology Dedicated to Newly Qualified Kidney Safety Biomarkers

A special May 10, 2010 issue of Nature Biotechnology (NBT) includes ten scientific publications from Critical Path Institute’s Predictive Safety Testing Consortium’s evaluation of seven kidney biomarkers for use in drug safety assessment.